State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR

Journal of Medical Virology

Volumn 64, Issue 4, 2001, Pages 410-418

  Kawai, Shigenobu ^a   Yokosuka, Osamu ^a   Imazeki, Fumio ^a   Maru, Yasushi ^a   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Integration

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA DETERMINATION; FEMALE; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS INTEGRATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0034973242     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.1066     Document Type: Article

References (69)

1. Sequence diversity and chromosomal distribution of young Alu repeats
2. Hepatocellular carcinoma and hepatitis B virus
3. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
4. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
5. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection
6. Hepatitis B virus and the prevention of primary hepatocellular carcinoma
7. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
8. State of hepatitis B virus DNA in liver diseases
9. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen
10. Impact of HBV, HCV and GBV-C/HGF on hepatocellular carcinomas in Europe
11. Occult hepatitis B infection in patients with chronic hepatitis C liver disease
12. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia
13. Occult hepatitis B virus as source of infection in liver transplant recipients
14. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat
15. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
16. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell
17. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-1 tax
18. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis
19. Hepatitis B virions isolated with antibodies to the pre-S1 dominant reveal occult viremia by PCR in Alaska native HBV carriers who have seroconverted
20. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients
21. State of hepatitis B viral DNA in the liver of patients with hepatocellular carcinoma and chronic liver disease
22. Hepatitis B virus pX targets TFIIB in transcription coactivation
23. Detection of hepatitis B virus DNA in hepatocellular carcinomas in Japan
24. A unique insertion in the S gene of surface antigen negative hepatitis B virus Chinese carriers
25. Integration of hepatitis B virus DNA in hepatocellular carcinoma
26. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus
27. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
28. Hepatitis C virus and hepatocellular carcinoma
29. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients
30. Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues
31. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient
32. Avoiding false positives with PCR
33. HCV and HBV coexist in HBsAg-negative patients with HCV viremia
34. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
35. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft
36. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
37. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements
38. State of hepatitis B viral DNA in a human hepatoma cell line
39. High prevalence of anti-hepatitis B virus
40. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
41. Hepatitis B virus persistence after recovery from acute viral hepatitis
42. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome
43. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma
44. Alu polymerase chain reaction
45. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease
46. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
47. Persistent of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients
48. Long-lasting memory T cell responses following self-limited acute hepatitis B
49. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II
50. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B
51. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein
52. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors
53. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma
54. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma
55. Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma
56. Transactivation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein
57. Trans-activation of viral enhancers by the hepatitis B virus X protein
58. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients
59. Hepatocellular carcinoma and the hepatitis B virus
60. Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues
61. Disruption of the function of tumor suppresser gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis
62. Transcriptional trans-activating function of hepatitis B virus
63. Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically native acute or chronic hepatitis
64. Transplantation of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants
65. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
66. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
67. Hepatitis B virus integration in hepatocellular carcinoma DNA
68. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen